Tune in to the J&J Innovation Podcast series featuring CureMatch’s CEO Stephane Richard. J&J’s host, Caroline Baratz goes in depth to discover more about the people behind innovative companies ushering in the latest trends in healthcare.
When it comes to cancer treatment in Mexico, just like in the United States, many cancer patients and their doctors still rely on traditional “one-size-fits-all” methods of care. CureMatch is looking to extend Precision Medicine technology to doctors and facilities responsible for any cancer treatment in Mexico.
A featured article in The Scientist magazine highlights CureMatch co-founder Dr. Razelle Kurzrock and her clinical use of personalized drug combinations therapies at the Center for Personalized Cancer Therapy at the University of California, San Diego. The advances in personalized cancer treatments appear to lead to better results for cancer patients. Check out the entire […]
CureMatch is honored to be selected to present at the 2018 Biocom Life Science Partnering Conference. The Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. CureMatch has developed a proprietary software platform aimed at guiding oncologists […]
Laguna Niguel, CA – December 13, 2017: Igor F. Tsigelny, Ph.D. and Eden Romm of CureMatch will be presenting at AIMed, the most comprehensive conference on Artificial Intelligence (AI) in medicine, on Wednesday, December 13. Romm and Tsigelny along with Valentina L. Kouznetsova authored “Machine-Learning Models for Selection of Drug-Candidates for Treatment of Alzheimer’s Disease”, one […]